Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Department of Genome Sciences, University of Washington, Seattle, Washington 98195, USA.
Genome Res. 2023 Mar;33(3):427-434. doi: 10.1101/gr.276696.122. Epub 2023 Feb 14.
Low-level DNA -methyldeoxyadenosine (DNA-m6A) has recently been reported across various eukaryotes. Although anti-m6A antibody-based approaches are commonly used to measure DNA-m6A levels, this approach is known to be confounded by DNA secondary structures, RNA contamination, and bacterial contamination. To evaluate for these confounding features, we introduce an approach for systematically validating the selectivity of antibody-based DNA-m6A methods and use a highly selective anti-DNA-m6A antibody to reexamine patterns of DNA-m6A in , , and Our findings raise caution about the use of antibody-based methods for endogenous m6A quantification and mapping in eukaryotes.
低水平的 DNA-甲基脱氧腺苷(DNA-m6A)最近在各种真核生物中都有报道。虽然基于抗-m6A 抗体的方法常用于测量 DNA-m6A 水平,但已知这种方法会受到 DNA 二级结构、RNA 污染和细菌污染的影响。为了评估这些混杂因素,我们引入了一种系统验证基于抗体的 DNA-m6A 方法选择性的方法,并使用高度选择性的抗-DNA-m6A 抗体重新检测 、 、 和 中的 DNA-m6A 模式。我们的研究结果对基于抗体的方法在真核生物中进行内源性 m6A 定量和作图提出了谨慎的看法。